Massachusetts Financial Services
YMAB

Massachusetts Financial Services’s Y-mAbs Therapeutics YMAB Stock Holding History

Massachusetts Financial Services’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-82,202
Closed -$993K – 900
2024
Q2 		$993K Buy
82,202
+2,760
+3% +$37.3K ﹤0.01% 800
2024
Q1 		$1.29M Sell
79,442
-175
-0.2% -$2.36K ﹤0.01% 763
2023
Q4 		$543K Sell
79,617
-2,514
-3% -$14.5K ﹤0.01% 798
2023
Q3 		$448K Buy
82,131
+59,201
+258% +$345K ﹤0.01% 811
2023
Q2 		$156K Buy
+22,930
New +$172K ﹤0.01% 819

Other funds holding YMAB

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Massachusetts Financial Services's YMAB Position: Q3 2024 in Review

Massachusetts Financial Services sold out of Y-mAbs Therapeutics (YMAB) in Q3 2024, closing a stake of 82,202 shares — an estimated $993K sold.

Massachusetts Financial Services first reported a position in YMAB in Q2 2023 and held it in 5 quarters. The position peaked at $1.29M in Q1 2024. 105 funds tracked by Wall St. Rank hold YMAB as of Q3 2024.

  • Massachusetts Financial Services reported no remaining Y-mAbs Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 82,202 Y-mAbs Therapeutics shares in Q3 2024, an estimated $993K.
  • Massachusetts Financial Services first reported a position in Y-mAbs Therapeutics in Q2 2023 and held it in 5 quarters.
  • Massachusetts Financial Services's Y-mAbs Therapeutics position peaked at $1.29M in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2024.

Based on Massachusetts Financial Services's 13F filing for Q3 2024, filed 12 Nov 2024.